ArticleCancer2013
Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
Article in Cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Economics of public health programs for underserved populations: a review of economic analysis of the National Breast and Cervical Cancer Early Detection Program.Cancer causes & control : CCC · 2019Pooled it
- Cost-Effectiveness of Community-to-Clinic Tailored Navigation for Colorectal Cancer Screening in an Underserved Population: Economic Evaluation Alongside a Group-Randomized Trial.American journal of health promotion : AJHP · 2022Trial
- Startup and implementation costs of a colorectal cancer screening tailored navigation research study.Evaluation and program planning · 2021Trial
- Trial
- Integrated interventions and supporting activities to increase uptake of multiple cancer screenings: conceptual framework, determinants of implementation success, measurement challenges, and research priorities.Implementation science communications · 2022Article
- Examining the relationship between household wealth and colorectal cancer screening behaviors among U.S. men aged 45-75.SSM - population health · 2022Article
- Source matters: a survey of cost variation for fecal immunochemical tests in primary care.BMC health services research · 2022Article
- Observational
- Economic Evaluation of Interventions to Increase Colorectal Cancer Screening at Federally Qualified Health Centers.Health promotion practice · 2020Article
- Developing a Web-Based Cost Assessment Tool for Colorectal Cancer Screening Programs.Preventing chronic disease · 2019Article
- A cost-effectiveness analysis of a colorectal cancer screening program in safety net clinics.Preventive medicine · 2019Article
- Article
- Observational
- Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.Evaluation and program planning · 2017Article
- Importance of implementation economics for program planning-evaluation of CDC's colorectal cancer control program.Evaluation and program planning · 2017Article
- Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.Annals of internal medicine · 2015Article
- Colonoscopy in Colorectal Cancer Screening: Current Aspects.Indian journal of surgical oncology · 2015Review
- Article
- Article
- Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program.Cancer · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe Centers for Disease Control and Prevention initiated the Colorectal Cancer Screening Demonstration Program (CRCSDP) to explore the feasibility of establishing a large-scale colorectal cancer (CRC) screening program for underserved populations in the United States. The authors of this report assessed the clinical costs incurred at each of the 5 participating sites during the demonstration period.
methodsBy using data on payments to providers by each of the 5 CRCSDP sites, the authors estimated costs for specific clinical services and overall clinical costs for each of the 2 CRC screening methods used by the sites: colonoscopy and fecal occult blood test (FOBT).
resultsAmong CRCSDP clients who were at average risk for CRC and for whom complete cost data were available, 2131 were screened by FOBT, and 1888 were screened by colonoscopy. The total average clinical cost per individual screened by FOBT (including costs for screening, diagnosis, initial surveillance, office visits, and associated clinical services averaged across all individuals who received screening FOBT) ranged from $48 in Nebraska to $149 in Greater Seattle. This compared with an average clinical cost per individual for all services related to the colonoscopy screening ranging from $654 in St. Louis to $1600 in Baltimore City.
conclusionsVariations in how sites contracted with providers and in the services provided through CRCSDP affected the cost of clinical services and the complexity of collecting cost data. Health officials may find these data useful in program planning and budgeting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.